Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers

"Self-monitoring through use of CoaguChek XS or InRatio2 PT/INR coagulometers has the potential to be cost-saving for CCGs as the increased frequency of INR monitoring may improve health outcomes by enabling the dose of therapy to be adjusted more accurately, thereby avoiding adverse events that can result from an inappropriate dose of long-term vitamin K antagonist therapy, such as stroke and major haemorrhage."

Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers: costing statement
NICE
September 2014

Read more here.